Bath & Body Works, Inc. (NYSE:BBWI) Receives $24.00 Average Price Target from Brokerages

Bath & Body Works, Inc. (NYSE:BBWI) has been given a consensus rating of “Hold” by the seventeen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Fourteen analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $24.00.

BBWI has been the subject of several research analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Tuesday, March 3rd. Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and boosted their price target for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. UBS Group upped their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, February 23rd. Finally, Zacks Research upgraded Bath & Body Works from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 20th.

Bath & Body Works Price Performance

NYSE BBWI opened at $18.30 on Wednesday. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of 5.81, a price-to-earnings-growth ratio of 1.83 and a beta of 1.50. Bath & Body Works has a 12 month low of $14.27 and a 12 month high of $34.66. The company’s fifty day moving average price is $20.81 and its two-hundred day moving average price is $21.64.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The business had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. During the same quarter in the prior year, the business posted $2.09 EPS. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date was Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is presently 25.40%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. AQR Capital Management LLC raised its stake in Bath & Body Works by 132.5% during the fourth quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock worth $229,834,000 after acquiring an additional 6,523,960 shares during the period. Alliancebernstein L.P. boosted its stake in Bath & Body Works by 2.2% in the third quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after acquiring an additional 123,648 shares during the period. American Century Companies Inc. grew its holdings in shares of Bath & Body Works by 2,204.1% during the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares during the last quarter. GMT Capital Corp grew its holdings in shares of Bath & Body Works by 8.8% during the second quarter. GMT Capital Corp now owns 4,067,000 shares of the company’s stock valued at $121,847,000 after purchasing an additional 329,300 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Bath & Body Works by 2.9% during the fourth quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock valued at $79,542,000 after purchasing an additional 110,602 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.